Stocks Health care CALC
NASDAQ · Health careCalciMedica, Inc. (CALC)
It posted a net loss of $21.2M. In fiscal 2025 capital spending exceeded operating cash flow by $21.2M. At June 30, 2026 it held $18.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
What CalciMedica, Inc. does
CalciMedica, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CALC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$29.6M | -$1.97 | -$21.2M |
| 2024 | n/a | -$13.7M | -$1.22 | -$21.2M |
| 2023 | n/a | -$34.4M | -$7.66 | -$25.8M |
| 2022 | n/a | -$7.8M | -$111.16 | -$11.8M |
| 2021 | n/a | -$35.8M | -$113.17 | -$32M |
| 2020 | n/a | -$27.5M | -$351.56 | -$33.1M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What CalciMedica, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 23, 2026
- September 16, 2026Other event 8-K
- September 2, 2026Other event 8-K
- August 27, 2026
- August 25, 2026Passive stake (5% or more) SCHEDULE 13G
- August 24, 2026Activist stake changed SCHEDULE 13D/A
- August 21, 2026Activist stake changed SCHEDULE 13D/A
- August 20, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running CalciMedica, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns CALC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Alafi Capital Company LLC13D, may seek influence with 1 related filers | 19.9% | August 24, 2026 |
| Armistice Capital, LLC13G, passive with 1 related filers | 9.99% | August 14, 2026 |
| Bering Partners II GP, L.L.C.13D, may seek influence with 3 related filers | 9.99% | August 21, 2026 |
| A. Rachel Leheny13D, may seek influence with 4 related filers | 9% | November 6, 2024 |
| Woodline Partners LP13G, passive | 8.1% | August 14, 2026 |
| Eric W. Roberts13D, may seek influence with 4 related filers | 6.4% | June 30, 2026 |
| Stonepine Capital Management, LLC13G, passive with 3 related filers | 6% | August 25, 2026 |
| CVI Investments, Inc.13G, passive with 1 related filers | 5.1% | July 20, 2026 |
Largest institutional holders
Insiders
Questions about CALC
What does CalciMedica, Inc. do?
CalciMedica, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CALC.
Is CalciMedica, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $21.2M.
When did CalciMedica, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from September 23, 2026.
Similar companies
Compare CALC with
Follow CALC
Get an email when CalciMedica, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CALC: get an email when it filesWhere the numbers come from
Financial figures are the values CalciMedica, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.